Results 121 to 130 of about 22,508 (191)

Give me a SINE: how Selective Inhibitors of Nuclear Export modulate autophagy and aging

open access: yesMolecular & Cellular Oncology, 2018
Autophagy is a cellular recycling process leading to lysosomal degradation of damaged macromolecules, which can protect cells against aging. The transcription factor EB (TFEB), a major transcriptional regulator of genes involved in autophagy and ...
A.V. Kumar   +5 more
doaj   +1 more source

Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors. [PDF]

open access: yesMed, 2022
Coutinho DF   +21 more
europepmc   +1 more source

Tumour-specific phosphorylation of serine 419 drives alpha-enolase (ENO1) nuclear export in triple negative breast cancer progression

open access: yesCell & Bioscience
Background The glycolytic enzyme alpha-enolase is a known biomarker of many cancers and involved in tumorigenic functions unrelated to its key role in glycolysis. Here, we show that expression of alpha-enolase correlates with subcellular localisation and
Morgan L Marshall   +3 more
doaj   +1 more source

Novel—and Not So Novel—Inhibitors of the Multifunctional CRM1 Protein

open access: yesOncology Reviews
Chromosome Region Maintenance 1 (CRM1), also known as Exportin 1 (XPO1), is a protein that is critical for transport of proteins and RNA to the cytoplasm through the nuclear pore complex.
Waitman K. Aumann   +5 more
doaj   +1 more source

FPGA-piirin testaus SystemVerilogilla [PDF]

open access: yes, 2009
Toimeksiantajana opinnäytetyössä oli CENTRIA, Keski-Pohjanmaan Ammattikorkeakoulun tutkimus- kehitys- ja täydennyskoulutusyksikkö. Työn aiheena oli FPGA- testaus SystemVerilogilla.
Aho, Heikki
core  

CD47 interactions with exportin-1 limit the targeting of m<sup>7</sup>G-modified RNAs to extracellular vesicles. [PDF]

open access: yesJ Cell Commun Signal, 2022
Kaur S   +14 more
europepmc   +1 more source

Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia

open access: yesPharmaceuticals
Background: Chronic myeloid leukemia is a hematological malignancy characterized by the abnormal proliferation of leukemic cells. Despite significant progress with tyrosine kinase inhibitors, such as Dasatinib, resistance remains a challenge.
Mariarita Spampinato   +17 more
doaj   +1 more source

Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis. [PDF]

open access: yesInt J Biol Sci, 2022
Ou L   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy